← Back to headlines
MPM Bioventures Funds Divest $615,777 in Entrada Therapeutics Shares
Investment vehicles managed by MPM Bioventures have sold approximately $615,777 worth of shares in biotechnology firm Entrada Therapeutics. The transaction reflects routine portfolio adjustments by the venture capital group.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
US-Iran Military Escalation Sparks Retaliatory Strikes and Market Volatility
27m ago
BP Appoints Ian Tyler as New Chairman Following Leadership Transition
33m ago
Everus Construction and California Resources Finalize Major Corporate Acquisitions
52m ago
Nvidia Nears $14 Billion Acquisition of AI Startup Hugging Face
1h ago